Brief: Procept Biorobotics Q4 Net Income USD -18.856 Million Vs. IBES Estimate USD -17.3 Million
25/02/2025 21:02
Feb 25 (Reuters) - Procept Biorobotics Q4 revenue USD 68.236 million vs. IBES estimate USD 66.8 million. Q4 operating income USD -19.71 million vs. IBES estimate USD -18.8 million Q4 gross profit USD 43.672 million Q4 basic EPS USD -0.35 Q4 adjusted EBITDA USD -10.335 million vs. IBES estimate USD -8.44 million outlook FY revenue USD 320 million outlook FY gross margin 64.5% outlook FY adjusted EBITDA USD -35 million outlook FY revenue growth 42%
Recent news on PROCEPT BioRobotics
See all newsU.S. STOCKS ON THE MOVE -VF Corp, Biogen, AbbVie
US STOCKS ON THE MOVE-SpaceX, Humana, AbbVie
U.S. STOCKS ON THE MOVE-SpaceX, Humana, Crescent Energy
MedTech growth concerns likely to overshadow Q3 results, Leerink says
Brief: Procept Biorobotics Corporation Enters Third Amendment To Loan And Security Agreement With Cibc